EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

mpMRI‐based MGMT methylation status prediction for glioblastoma through off‐the‐shelf deep features: A multi‐dataset feasibility study

Junhua Chen, Zhanghong Wang, Banghua Yang

Journal of Applied Clinical Medical Physics · 2025-12 · 26 (12)

DOI: 10.1002/acm2.70373 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, online erschienen am 23.11.2025. Verfasst von Junhua Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychology, Mental Health Center Affiliated to Shanghai University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Glioblastoma, DNA Modification Methylases, Tumor Suppressor Proteins, Brain Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Shanghai University School of Medicine "Open Bidding" Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

O‐6‐methylguanine DNA methyltransferase (MGMT) promoter methylation status is a critical prognostic factor in glioblastoma. The aim of this study is to evaluate the feasibility of diagnosing MGMT status in a rapid, non‐invasive manner using multiparametric magnetic resonance imaging (mpMRI). The proposed method seeks to reduce reliance on stakeholders, thereby facilitating potential clinical applications in the future. Materials and methods This study employed a Siamese neural network (SNN) as the backbone of the model to effectively leverage information from various mpMRI modalities. Off‐the‐shelf deep learning features extracted from pre‐trained networks was used to represent the information from mpMRI and adopted as the inputs of SNN. Delta deep features from T1 modality were integrated as additional branch of SNN to enhance model's performance. Finally, external validation was performed to increase the robustness of study. The proposed method was applied to one of the largest publicly available mpMRI datasets, comprising 585 participants, with an additional 81 samples used for external validation.

Results

The proposed method achieved an average area under the curve (AUC) of 0.666 with a standard error of the mean (SEM) of 0.031, average precision of 0.591 (SEM 0.021), and average recall of 0.630 (SEM 0.064). In external validation, the method yielded an average AUC of 0.624 (SEM 0.022), precision of 0.674 (SEM 0.050), and recall of 0.810 (SEM 0.101).

Conclusion

The results demonstrate that our method outperforms existing approaches on a single‐CPU platform. Ablation studies confirmed the effectiveness of incorporating delta T1 deep features, while external validation confirmed the method's reliability across different datasets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaDNA Modification MethylasesTumor Suppressor ProteinsBrain NeoplasmsDNA MethylationDNA Repair EnzymesMultiparametric Magnetic Resonance ImagingDeep LearningHumansFeasibility StudiesMaleFemaleNeural Networks, ComputerMiddle AgedPrognosisAdult

Stichwörter der Autor:innen

MGMT promoterdelta deep featuresoff‐the‐shelf deep featuresradiogenomics for glioblastoma

Substanzen

MGMT protein, humanDNA Modification MethylasesTumor Suppressor ProteinsDNA Repair Enzymes

Autor:innen und Institutionen

  • Department of Psychiatry and Psychology, Mental Health Center Affiliated to Shanghai University School of Medicine, Shanghai, China.
  • Department of Anesthesiology, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Wenzhou, Zhejiang, China.
  • School of Mechatronic Engineering and Automation, Shanghai University, Shanghai, China.

Förderung

  • National Key Research and Development Program of China
  • Shanghai University School of Medicine "Open Bidding" Project

Zitieren

APA

Chen, J., Wang, Z., & Yang, B. (2025). mpMRI‐based MGMT methylation status prediction for glioblastoma through off‐the‐shelf deep features: A multi‐dataset feasibility study. Journal of Applied Clinical Medical Physics, 26(12). https://doi.org/10.1002/acm2.70373

Vancouver

Chen J, Wang Z, Yang B. mpMRI‐based MGMT methylation status prediction for glioblastoma through off‐the‐shelf deep features: A multi‐dataset feasibility study. Journal of Applied Clinical Medical Physics. 2025;26(12). doi:10.1002/acm2.70373

BibTeX
@article{Chen2025,
  author = {Chen, Junhua and Wang, Zhanghong and Yang, Banghua},
  title = {mpMRI‐based MGMT methylation status prediction for glioblastoma through off‐the‐shelf deep features: A multi‐dataset feasibility study},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2025},
  volume = {26},
  number = {12},
  doi = {10.1002/acm2.70373}
}
Kostenlos starten →